
Abstract Background and aims: Insulin resistance may be closely related to the occurrence and development of chronic liver diseases (CLD). But, the relationship between triglyceride-glucose (TyG) index and CLD is still unknown. This study aimed to prospectively investigate the association between TyG index and CLD in Chinese middle aged and elderly adults. Methods: A total of 9156 participants from the China Longitudinal Study of Health and Retirement aged 45 years and older were included. The participants were divided into four groups based on the TyG index quartiles. A cox regression model was established to analyze the correlation between TyG index and CLD. Results: During 7-year follow up, 541 (5.91%) participants developed CLD. The hazard ratio (95% confidence interval) for the highest quartile of TyG index, TyGBMI, and TyGwaist was 1.42(1.10-1.83), 1.62(1.25-2.09) and 1.40(1.09-1.81) after full adjustment, respectively, with the lowest quartiles as the reference. Similarly, TyG index, TyGBMI, and TyGwaist exhibited a linear dose-response relationship with CLD (all P linearity <0.001). Furthermore, the addition of TyG-related indices to the conventional model significantly improved reclassification and comprehensive identification of risk of CLD. Conclusions: Higher TyG index was associated with increased risk of CLD, independently of established risk factors. The TyG index may be a predictor of incident CLD.
Rivaroxaban (RVN) is a direct Factor Xa inhibitor used in the management of thromboembolic disorders; even so, its therapeutic efficacy is restricted by its poor aqueous solubility, variable oral bioavailability, and extensive first-pass hepatic metabolism. In the present study, a mucoadhesive buccal gel incorporating a rivaroxaban-loaded self-nanoemulsifying drug delivery system (RVN-SNEDDS) was formed and optimized to enhance drug dissolution, mucosal permeation, and systemic bioavailability. RVN-SNEDDS was developed and enclosed into buccal gels formulated with carbomer, hyaluronic acid, or their combination. A factorial design method was applied to investigate the influence of polymer system and concentration on mucoadhesive strength, rheological properties, spreadability, and in vitro drug release. The optimized formulation showed rapid initial drug release, with about one-third of the drug released within the first 5 min and more than 85 +/- 4.23% released within 30 min, followed by sustained release behavior. Ex vivo permeation studies showed significantly increase in rivaroxaban transport across buccal mucosa in comparison to conventional formulations. In vivo pharmacokinetic evaluation in rabbits revealed a faster onset of action and a marked increase in systemic bioavailability in compare to the marketed oral tablet. Stability studies confirmed the physical and chemical stability of the optimized gel under storage conditions. These findings show that incorporation of rivaroxaban into a self-nanoemulsifying system followed by formulation into a mucoadhesive buccal gel is a promising strategy for improving drug delivery and therapeutic performance.
Abstract Introduction: The Geriatric Nutritional Risk Index (GNRI) is an established index for assessing nutritional risk and is associated with adverse outcomes in chronic kidney disease; however, its relationship with renal histopathological findings remains unclear. We investigated the associations of GNRI with renal pathological findings and renal outcomes in patients undergoing native kidney biopsy. Methods: This single-center retrospective study was a secondary analysis of a previously established cohort of 503 native kidney biopsy patients with evaluable renal medullary tissue. After excluding patients with nephrotic-range proteinuria, tubulointerstitial nephritis, antineutrophil cytoplasmic antibody-associated vasculitis, anti-glomerular basement membrane disease, and polyarteritis nodosa, 308 patients were analyzed. Patients were stratified by median GNRI, and the primary outcome was a composite of a ≥40% decline in estimated glomerular filtration rate or initiation of renal replacement therapy. Associations were evaluated using multivariable linear regression and Cox proportional hazards models. Results: During a median follow-up of 2.4 years, 62 patients (20.1%) reached the renal outcome. Lower GNRI was independently associated with older age, greater proteinuria, and greater cortical interstitial inflammatory cell infiltration, but not with cortical interstitial fibrosis and tubular atrophy (IFTA). In addition, lower GNRI was independently associated with adverse renal outcomes (adjusted hazard ratio [HR], 1.90; 95% confidence interval [CI], 1.10–3.29), and the association persisted after adjustment for cortical IFTA (HR, 1.86; 95% CI, 1.08–3.23). Addition of GNRI improved C-index from 0.673 to 0.698 and significantly improved model fit beyond established clinical factors and cortical IFTA (likelihood ratio test, P = 0.024). Conclusion: In patients undergoing kidney biopsy, lower GNRI was associated with renal interstitial inflammation rather than chronic fibrosis and was independently associated with adverse renal outcomes.
Abstract Introduction: Despite WHO recommendation for 6-month exclusive breastfeeding, some infants transitioning to formula feeding before then may experience infant regurgitation. This study compared the effects of whole goat milk-based infant formula (WGF) and cow milk protein-based infant formula (CF) on regurgitation along with stress and inflammatory biomarkers during the first 4-week of transition. Methods: Healthy full-term infants were randomized 1:1 to WGF or CF within 7 days of starting formula alongside breastfeeding. A predominant breastfeeding(PBF) group was investigated as reference. Daily regurgitation frequency was prospectively recorded for 4 weeks. Salivary cortisol, C-reactive protein(CRP), alpha amylase(AA), and secretory IgA(sIgA) were measured by ELISA at baseline and 2-week post-randomization. Results: Eighty infants were randomized [40 WGF, 40 CF; mean age 7.2(95%CI6.2-8.3) vs 9.2(7.8-10.5) weeks], and 59 served as the PBF reference. Baseline daily regurgitation did not differ between formula groups [WGF 2(1.4-2.6) vs CF 1.5(1.1-2) times/day]. Changes in daily regurgitation from baseline to 2 and 4 weeks did not differ between the WGF and CF groups. There were no significant between-group differences for all salivary biomarkers. However, cortisol and CRP decreased significantly within the WGF group, [cortisol:0.62(0.46-0.79) to 0.43(0.33-0.52)µg/dL,p=0.01;CRP:522.3(360.3-684.4) to 393.5(258.5-528.6)pg/mL,p=0.045], reaching levels comparable to PBF, whereas no significant changes were observed in the CF group. Conclusions: This prospective exploratory study found no significant differences in daily infant regurgitation or salivary biomarkers between WGF and CF during transition from breastfeeding, although WGF showed a decrease in stress and inflammation biomarkers. Study in a larger population is warranted to confirm the clinical significance. ClinicalTrials.gov(NCT05363553)
The present research aims to formulate and evaluate an optimized doxorubicin (DOX)-resveratrol incorporated nanoscale lipid carrier (DOX-RES-NLC) gel for delivery through the transdermal route for breast cancer treatment. The central composite rotatable design was utilized to optimize the preparation. DOX and RES showed a synergistic effect in a 1:4 ratio in MCF-7 cell lines, determined by the combination index (CI). Transmission electron microscopy (TEM) displayed the globular structure of NLC. Permeation study of dual drug-loaded NLC was performed using Strat-M, which showed flux and permeation coefficient of DOX and RES from NLC gel were 17.96 mu g/cm2/h; 1.79*10-2 cm/h, and 14.33 mu g/cm2/h; 0.36*10-2 cm/h, respectively. The treated and untreated skin samples were analyzed using DSC and FT-IR spectrometry to determine the mechanism behind the permeation of NLC gel. The permeation extent using confocal laser scanning microscopy (CLSM) showed permeation of drugs from the NLC gel was 2-fold deeper in contrast to conventional gel. HET-CAM study demonstrated that DOX-RES-NLC was nonirritant. Cytotoxicity study showed DOX-RES-NLC was better at killing cells in comparison to the DOX-RES-suspension with values of IC50 values of 15.04 and 27.31 & micro;M, respectively. These findings support the potential of the developed NLC gel as a transdermal delivery system and provide a rational basis for further in vivo investigation.